Wederfoort Jamilla L M, Trommelen Darius A X, Al Tarah Mohammad, Hommes Juliette E, van Kuijk Sander M J, van der Hulst René R W J, Piatkowski Andrzej A
Department of Plastic, Reconstructive, and Hand Surgery, Maastricht University Medical Center+, Maastricht, the Netherlands; NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands.
Department of Plastic, Reconstructive, and Hand Surgery, Maastricht University Medical Center+, Maastricht, the Netherlands.
J Plast Reconstr Aesthet Surg. 2024 Dec;99:317-328. doi: 10.1016/j.bjps.2024.09.083. Epub 2024 Sep 29.
Reconstructive surgeons have shifted from correcting contour irregularities using autologous fat transfer (AFT) toward reconstructing full breasts. Although several studies have researched the volumetric aspects of AFT, some outcomes such as volume retention, viability, and possible confounders for graft survival, remain unclear. This study aimed to answer these questions.
Post-mastectomy women of the multicenter prospective BREAST-trial were randomized to either AFT breast reconstruction or implant-based reconstruction (IBR). Volumes were assessed using the Vectra 3D imaging system and compared at 12 months post-operative. Volume retention was defined as the augmented volume divided by the lipofilling volume. Significant confounders for graft survival were identified using multivariable regression analysis.
A total of 148 patients (75 AFT, 73 IBR) were included in the final analyses. Post-operative volumes differed significantly at 12 months in favor of the IBR group (83.8 ml, p < 0.001). For AFT patients, graft survival did not decrease between 6 and 12 months, with a mean graft survival of 37.1% at 12 months. Significant confounders for graft survival included chest circumference (β = 1.107, p = 0.001), comorbidities (β = 28.567, p = 0.002), age (β = -0.514, p = 0.007), and total lipofilling (β = -0.028, p < 0.001).
Plastic surgeons can reconstruct voluminous breasts post-mastectomy using only AFT, and these breast volumes stabilize at 6 months and VECTRA 3D is reliable for breast volume measurement. Approximately a third of the grafted fat was calculated to survive post-operatively and reconstructive surgeons should be aware not to transfer too much fat in one session.
重建外科医生已从使用自体脂肪移植(AFT)矫正轮廓不规则转向全乳重建。尽管有多项研究探讨了AFT的体积方面,但一些结果,如体积保留、存活率以及移植物存活的可能混杂因素仍不明确。本研究旨在回答这些问题。
多中心前瞻性BREAST试验中的乳房切除术后女性被随机分为AFT乳房重建组或植入物乳房重建组(IBR)。使用Vectra 3D成像系统评估体积,并在术后12个月进行比较。体积保留定义为增大体积除以脂肪填充体积。使用多变量回归分析确定移植物存活的显著混杂因素。
最终分析纳入了148例患者(75例AFT,73例IBR)。术后12个月时,两组体积差异显著,IBR组更具优势(83.8毫升,p < 0.001)。对于AFT患者,移植物存活率在6至12个月之间没有下降,12个月时平均移植物存活率为37.1%。移植物存活的显著混杂因素包括胸围(β = 1.107,p = 0.001)、合并症(β = 28.567,p = 0.002)、年龄(β = -0.514,p = 0.007)和总脂肪填充量(β = -0.028,p < 0.001)。
整形外科医生仅使用AFT即可在乳房切除术后重建大容量乳房,这些乳房体积在6个月时稳定,Vectra 3D用于乳房体积测量可靠。据计算,术后约三分之一的移植脂肪存活,重建外科医生应注意不要在一次手术中转移过多脂肪。